Background-Cardiac resynchronization therapy (CRT) is a relatively new treatment strategy for patients with heart failure and mechanical asynchrony. Reported effects of CRT on regional myocardial blood flow (MBF) are conflicting, and effects on hyperemic MBF are scarce. The aim of the present study was to assess serial changes of MBF and MBF reserve in patients receiving a biventricular pacemaker. Methods and Results-Fourteen patients with heart failure (NYHA class III or IV; left ventricular ejection fraction Ͻ35%), QRS width Ͼ120 ms, and sinus rhythm were studied (mean age, 58Ϯ10 years; 8 men). MBF and hyperemic MBF were measured at baseline, 3 months after biventricular pacing (CRT on), and after cessation of pacing (CRT off) with PET and H 2
I
n recent years, cardiac resynchronization therapy (CRT) has emerged as a new treatment strategy for a subgroup of patients with heart failure and an asynchronous contraction pattern. 1, 2 It has been demonstrated that CRT improves hemodynamic function, 3, 4 heart failure symptoms, exercise capacity, and quality of life (QOL) and that it reduces morbidity and mortality. 5 A number of studies have shown that function improves without an increase in oxygen consumption, indicating increased efficiency. 6 -9 Furthermore, oxygen consumption seems to be distributed more homogeneously during CRT. 7 These findings support the hypothesis that CRT rebalances the loading condition of the heart. 1, 2 Changes in oxygen consumption are expected to be accompanied by similar changes in myocardial blood flow (MBF). Nevertheless, conflicting results have been reported with regard to the effects of CRT on regional MBF. 6,8,10 -13 These studies, however, are difficult to compare because MBF was evaluated with different imaging modalities and at varying follow-up periods. In addition, in none of these studies were serial measurements performed before, during, and after cessation of pacing therapy. Furthermore, data on the effects of CRT on MBF reserve are scarce, 9 despite its important role in the pathophysiology of the failing heart. Therefore, the present study was performed to serially assess the effects of CRT on regional MBF and MBF reserve with PET and H 2 15 O.
Methods Patients
Sixteen consecutive patients with heart failure (NYHA class III or IV despite optimized medical therapy), left ventricular ejection fraction (LVEF) Ͻ35%, intraventricular conduction delay (QRS width Ͼ120 ms), LV end-diastolic diameter Ͼ55 mm, and sinus rhythm were enrolled in the study. The cause of heart failure was idiopathic dilated cardiomyopathy in 9 patients and ischemic heart failure in 7. Angiography revealed severe coronary artery disease not eligible for further revascularization procedures in 4 of these patients. The remaining 3 patients had suffered from large myocardial infarctions leading to heart failure. No significant coronary artery stenoses were present after percutaneous interventions in the latter patients. At the time of enrollment, all patients were in a clinically stable condition on standard heart failure medication, including ACE inhibitors (nϭ14), angiotensin receptor antagonist (nϭ2), ␤-blockers (nϭ13), diuretics (nϭ14), and digoxin (nϭ3). The doses of this background medication were stable for Ն3 months. Medication was kept constant during the study. Serial resting MBF and hyperemic MBF measurements were performed Ͻ1 month before and 3 months after biventricular pacemaker implantation. The postimplantation measurements were performed both during biventricular pacing (CRT on) and shortly after reprogramming the pulse generator to AAI mode with a lower rate of 40 bpm (CRT off). Effectively, the latter pacing mode results in a normal sinus rhythm comparable to baseline. The order of the postimplantation studies was randomized. In 8 patients, this sequence was "on-off"; in the remaining 6, it was "off-on." Two patients died during the follow-up period because of sudden death and progressive pump failure, resulting in 14 completed protocols. QOL was assessed with the Minnesota Living With Heart Failure questionnaire 14 before and after 3 months of CRT. Scores range from 0 to 105; higher scores reflect a worse QOL. All subjects gave written informed consent, and the Medical Ethics Committee of the VU University Medical Center approved the protocol.
Biventricular Pacemaker Implantation
Three transvenous pacing leads were inserted, 1 in the atrial appendage and 1 in the right ventricular apex. In addition, a coronary sinus lead was positioned in the posterolateral (nϭ12) or anterolateral (nϭ4) position. The pacing leads were connected to a biventricular pacemaker (either Insync II, Medtronic, or Triplos LV, Biotronik). The pacemaker was programmed in DDD mode. A predischarge AV optimization was performed in all patients. 15 
Positron Emission Tomography
All scans were performed in 2D mode with an ECAT EXACT HRϩ (Siemens CTI). Subjects were constantly monitored with single-lead ECG, and blood pressure was measured every 3 minutes. After a transmission scan, 1100 MBq of H 2
15
O dissolved in 5 mL saline was injected intravenously via a pump in 2 seconds, followed by a 40-mL saline flush at a rate of 4 mL/s (bolus injection). A dynamic scan was acquired, consisting of 40 frames with variable frame length for a total time of 10 minutes (12ϫ5, 12ϫ10, 6ϫ20, and 10ϫ30 seconds). After the rest study, a hyperemic study was performed by infusing adenosine at a rate of 140 g · kg Ϫ1 · min Ϫ1 . Subsequently, blood pool imaging was performed. During a 2-minute period, the patient inhaled Ն2000 MBq of C 15 O, and a single frame was acquired for a duration of 6 minutes, starting 1 minute after the end of inhalation to allow for equilibration in the blood pool.
The postimplantation study was identical to the baseline study except that resting MBF and hyperemic MBF measurements were performed both during CRT on and CRT off.
Emission data were corrected for physical decay of 15 O and for dead time, scatter, randoms, and photon attenuation. Reconstruction of the H 2
O emission sinograms was performed with filtered back projection with a Hanning filter at 0.5 of the Nyquist frequency, resulting in a transaxial spatial resolution of Ϸ7 mm full width at half-maximum.
Anatomic tissue images were generated by subtracting the blood pool image from the transmission image 16 and resliced into shortaxis images according to the anatomic axis of the heart. The same reslicing parameters were automatically applied to the dynamic H 2
O images. Thirteen regions of interest (ROIs) (6 basal, 6 distal, 1 apical) were defined as described previously. 17 Additional ROIs were defined on the anatomic tissue images in left and right ventricular chambers for image-derived input functions. The set of ROIs was projected onto the dynamic H 2 15 O images to generate time-activity curves. With the standard single-compartment model, MBF (mL · min Ϫ1 · mL Ϫ1 of perfusable tissue) was determined from these time-activity curves. Corrections were made for left and right ventricular spillover effects by use of the method described by Hermansen et al. 18 Global MBF was calculated by grouping all ROIs. In addition, septal and lateral MBFs were determined by grouping of the corresponding septal and lateral ROIs. MBF reserve was calculated as the ratio of hyperemic MBF to resting MBF. Because resting MBF is related to the rate-pressure product (RPP; RPPϭsystolic blood pressureϫheart rate), corrected resting MBF (MBF/RPPϫ10.000) was also determined. Myocardial vascular resistance was calculated by dividing mean arterial pressure by MBF.
Echocardiography
All patients underwent complete 2D and Doppler echocardiography at baseline and after 3 months of follow-up to determine LV and valve function. Standard parasternal and apical views were recorded on VHS videotape for subsequent offline analysis. LV end-diastolic volume (LVEDV), LV end-systolic volume, LVEF, LV mass, LV ejection time, and LV filling time were determined according to the recommendations of the American Society of Echocardiography. 19 The ratio of LVEDV to LV mass (LVM) was calculated as a reflection of global end-diastolic LV wall tension, as described by Gaasch. 20 
Diastolic Perfusion Time Calculation
The R-R interval was measured at rest and during hyperemia on the ECGs obtained during the PET scans. Diastolic perfusion time {DPT; DPT (s/min)ϭ[(R-R intervalϪLV ejection time)ϫheart rate]} 21, 22 was calculated during baseline and CRT on for both rest and hyperemia.
Statistical Analysis
Data were expressed as meanϮSD. For comparison of 2 data sets, a paired Student's t test was performed. Intragroup comparisons of hemodynamic and PET data were tested for significance with a general linear model for repeated measures (MANOVA). Linear regression was used to test the relationship between variables. A value of PϽ0.05 was considered significant. All analyses were performed with SPSS 9 (SPSS Inc).
Results
Biventricular pacemaker implantation was uncomplicated in all 14 patients. Patient characteristics are summarized in Table 1 . Table 2 lists the hemodynamic results. CRT did not have an effect on heart rate or blood pressure. Infusion of adenosine consistently caused an increase in heart rate and a decrease in systolic blood pressure, resulting in a higher RPP. 
Hemodynamic Data

Myocardial Blood Flow
There were no significant differences in resting global MBF between the 3 measurements (Table 3 and Figure 1) ; PϭNS), although both showed an increase in hyperemic MBF during CRT. Mean QOL score and NYHA class decreased by 19% and 0.86, respectively (both PϽ0.01). However, nonischemic patients tended to benefit more from CRT (QOL score and NYHA class decrease, 23% and 1.0, respectively) than ischemic patients (decrease, 15% and 0.67, respectively).
MBF Distribution Pattern
At baseline, resting MBF distribution was inhomogeneous with a septal-to-lateral ratio (SLR) of 0.77Ϯ0. 27 . CRT resulted in a more homogeneous resting MBF pattern, with an SLR of 0.97Ϯ0.34 (Pϭ0.049 versus baseline). SLR returned to baseline after cessation of CRT (0.77Ϯ0.26, Pϭ0.023 versus CRT; Figure 3 ). There were no significant changes in SLR for hyperemic MBF during CRT (Table 3) .
Echocardiography
At baseline, mean LVEDV, LV end-systolic volume, and LVEF were 273Ϯ84 mL, 207Ϯ72 mL, and 25Ϯ7%, respectively. After 3 months of CRT, LV end-systolic volume decreased to 164Ϯ69 mL (PϽ0.01). Although not significant, LVEDV decreased to 256Ϯ88 mL (Pϭ0.08). LVEF increased to 37Ϯ9% (PϽ0.01). Filling time increased from 
Interrelation Among Measured Parameters
There was a significant relation between the decrease in wall stress, expressed as the LVEDV/LVM ratio, and increase in hyperemic MBF during CRT compared with baseline ( Figure  4 ), whereas there was no correlation between changes in hyperemic DPT time and hyperemic MBF ( Figure 5 ).
Discussion
Resynchronization therapy is a relatively new treatment for patients with heart failure and mechanical LV dyssynchrony, usually identified by the presence of intraventricular conduction delay such as left bundle-branch block. 1,2 Left bundlebranch block reduces myocardial perfusion in the septum because of impaired systolic thickening and augmented intramyocardial pressure in the septum. 24 The present findings also demonstrate an inhomogeneous perfusion pattern, with a reduced SLR of resting MBF. In line with data from Nowak et al 10 using SPECT, CRT was found to have a homogenizing effect on perfusion. Similar effects on perfusion were observed by the same group using PET. 13 Although not significant, septal perfusion increased and lateral perfusion decreased. Ukkonen et al 7 also demonstrated a more even distribution of oxygen consumption during CRT. After 3 months of pacing, changes in regional perfusion were completely reversible after cessation of CRT. These results suggest that CRT rebalances the loading conditions of the heart. Furthermore, improvement in LV function was not accompanied by an increase in global MBF. Because MBF is closely coupled to oxygen consumption, this suggests improved efficiency, confirming the pioneering work of Nelson and coworkers. 6 The main finding of the present study was the effect of CRT on hyperemic MBF and MBF reserve. Both parameters increased during CRT compared with baseline and decreased after cessation of CRT to values similar to those found at baseline. We explored the role of changes in wall stress and DPT in relation to the observed changes in hyperemic perfusion.
First, congestive heart failure is accompanied by increased LV filling pressures and wall stress. Myocardial perfusion may be affected by these increased pressures through extravascular compression of the coronary vascular bed. 22, 25 Under baseline conditions, however, myocardial perfusion is autoregulated at the microvascular level in response to varying demand. 26 Therefore, changes in LV filling pressures and wall stress do not affect resting myocardial perfusion because the microvascular bed has the capability of compen- sating for these changes by vasodilatation. 27 During pharmacologically induced maximum vasodilatation, however, this autoregulatory mechanism is exhausted, and augmentation of filling pressures and wall stress might lead to a reduction in hyperemic myocardial perfusion. 28 CRT results in a reduction in LV filling pressures and wall stress. 1, 2 The reduction in LVEDV/LVM ratio, as a reflection of end-diastolic wall stress, was directly related to the increase in hyperemic MBF during CRT in the present study, supporting the hypothesis of a relation between the 2 parameters.
Second, myocardial perfusion is a predominantly diastolic process. Dyssynchrony of the heart reduces diastole by prolonging the overall tension development time during the cardiac cycle 29 and shortening of LV filling time. 30 The latter phenomenon is even more pronounced in patients with dilated cardiomyopathy. 30 In the presence of autoregulation of vascular tone, myocardial perfusion is unaffected by changes in DPT. A reduction in DPT, however, could cause a reduction in hyperemic MBF when autoregulation is abolished. 22 Resynchronization of the heart by means of biventricular pacing increases diastolic filling time, 3, 31 which may prolong DPT. CRT could therefore in theory be responsible for the enhanced hyperemic perfusion observed in the present study. DPT, however, was unaltered in the present study because ejection time is hardly affected by CRT, 32 even though filling time was increased. Furthermore, there was no correlation between the change in hyperemic DPT and hyperemic MBF in our study population. Our data suggest that, in contrast to wall stress, DPT does not play an important role in the changes observed in hyperemic perfusion during CRT.
Independent of the mechanism for the increase in hyperemic MBF and MBF reserve, the observation is important from a pathophysiological point of view. Impairment of MBF reserve in congestive heart failure, independent of its cause, is believed to cause repetitive stunning (intermittent periods of ischemia), leading to chronic reversible LV dysfunction, which in turn is associated with an adverse prognosis. 33, 34 Restoration of flow reserve by revascularization therapy can induce recovery of function and improve prognosis. 33 Although the benefit of biventricular pacing is related to mechanical resynchronization of the interventricular septum and lateral free wall, the present study suggests that enhancement of MBF reserve might also play a role in the recovery of function associated with CRT.
Follow-up PET studies were performed after 3 months of CRT. In general, reverse remodeling occurs over this period of time. 3, 4 The reversed remodeling process could have contributed to the effects of CRT on myocardial perfusion. The immediate return to baseline values after cessation of pacing, however, suggests that the effect of remodeling is limited. Furthermore, once reverse remodeling has occurred, some of the benefits of CRT are lost gradually over time after suspension of pacing. 3 This is in contrast to the acute changes in regional MBF and hyperemic MBF observed in the present study.
Because the present study population was relatively small, the value of subgroup analyses is very limited. There was, however, a tendency toward greater augmentation of hyperemic MBF by CRT in nonischemic than in ischemic patients. Flow-limiting stenoses and the presence of scar tissue may be responsible for these differences.
Recently, Sundell et al 9 did not observe a significant change in hyperemic MBF after cessation of CRT in 10 nonischemic heart failure patients after an average period of 8 months of pacing, although a slight decrease occurred. A possible explanation for the discrepancy between that study and the present one could be a difference in patient population. Hyperemic perfusion after cessation of CRT was substantially lower compared with nonischemic patients in our study (1.6Ϯ0.9 versus 2.5Ϯ1.0 mL · min Ϫ1 · mL Ϫ1 ), indicating a more advanced stage of dilated cardiomyopathy. 28, 34 Interestingly, in the present study, enhancement of hyperemic perfusion was observed predominantly in patients with relatively preserved baseline hyperemic perfusion (Figure 2 ), which may be responsible for the discrepancy compared with the results from Sundell et al. 9 This issue, in addition to underlying mechanisms responsible for the perfusion changes during CRT, needs to be addressed in future studies.
Conclusions
CRT does not alter resting MBF despite an increase in LV function, suggesting increased efficiency. The heterogeneous regional distribution of resting MBF, however, is normalized by CRT. Furthermore, hyperemic MBF and consequently MBF reserve are enhanced by CRT.
